Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Clinical trial NCT03683719 · COMPLETED

Trial details

NCT number: NCT03683719
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hand Eczema

Start date: 2018-11-28
Primary completion: 2020-03-06
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.